Detection of apoptosis by RT–PCR array in mefloquine–induced cochlear damage

Journal of Otology

Volumn 6, Issue 1, 2011, Pages 1-9

  Ding, Da–lian ^a,d,e,f   Shinichi, Someya ^b   Hai–yan, Jiang ^a   Wei–dong, Qi ^a,c   Dong–zhen, Yu ^a,d   Tanokura, Masaru ^e   Salvi, Richard ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c FUDAN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^e UNIVERSITY OF TOKYO   (Japan)

^f CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

apoptosis; cochlea; gene expression; hair cells; mefloquine; ototoxicity; spiral ganglion neurons

Indexed keywords

EID: 84892417284     PISSN: None     EISSN: 16722930     Source Type: Journal    
DOI: 10.1016/S1672-2930(11)50001-7     Document Type: Article

References (29)

1. Sturchler, D., Handschin, J., Kaiser, D., et al. Neuropsychiatric side effects of mefloquine. N Engl J Med 322:24 (1990), 1752–1753.
2. Weinke, T., Trautmann, M., Held, T., et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 45:1 (1991), 86–91.
3. Hennequin, C., Bouree, P., Bazin, N., et al. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med 154:20 (1994), 2360–2362.
4. Phillips–Howard, P.A., ter Kuile, F.O., CNS adverse events associated with antimalarial agents. Fact or fiction?. Drug Saf 12:6 (1995), 370–383.
5. Croft, A.M., World, M.J., Neuropsychiatric reactions with mefloquine chemoprophylaxis. Lancet, 347(8997), 1996, 326.
6. Schlagenhauf, P., Mefloquine for malaria chemoprophylaxis 1992–1998: a review. J Travel Med 6:2 (1999), 122–133.
7. Rendi–Wagner, P., Noedl, H., Wernsdorfer, G., et al. Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. Acta Trop 81:2 (2002), 167–173.
8. McArdle, J.J., Sellin, L.C., Coakley, K.M., et al. Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals. Neuropharmacology 50:3 (2006), 345–353.
9. Dow, G., Bauman, R., Caridha, D., et al. Mefloquine induces dose–related neurological effects in a rat model. Antimicrobial Agents and Chemotherapy 50:3 (2006), 1045–1053.
10. McArdle, J.J., Sellin, L.C., Coakley, K.M., et al. Mefloquine inhibits cholinesterases at the mouse neuromuscular junction. Neuropharmacology 49:8 (2005), 1132–1139.
11. Fusetti, M., Eibenstein, A., Corridore, V., et al. Mefloquine and ototoxicity: a report of 3 cases. Clin Ter 150:5 (1999), 379–382.
12. Ding, D., Qi, W., Yu, D., et al. Ototoxic effects of mefloquine in cochlear organotypic cultures. Journal of Otology 4:2 (2009), 29–38.
13. Yu, D., Ding, D., Jiang, H., et al. Mefloquine Damage Vestibular Hair Cells in Organotypic Cultures. Neurotox Res, 2010.
14. Ding, D., Wang, P., Jiang, H., et al. Gene expression in cisplatin ototoxicity and protection with p53 inhibitor. Chinese Journal of Otology 4:2 (2009), 15–24.
15. Ding, D., Jiang, T., Qi, W., et al. Science of the inner ear. Chinese Science and Technology Publishing Company, 2010, 39–49.
16. Jiang, H., Ding, D., Salvi, R., Mefloquine–induced changes in apoptotic gene expression in cochlear basilar membrane and spiral ganglion neurons. Abstr Assoc Res Otolaryngol, 2008.
17. Hu, B.H., Cai, Q., Manohar, S., et al. Differential expression of apoptosis–related genes in the cochlea of noise–exposed rats. Neuroscience 161:3 (2009), 915–925.
18. Wei, L., Ding, D., Salvi, R., Salicylate–induced degeneration of cochlea spiral ganglion neurons–apoptosis signaling. Neuroscience 168:1 (2010), 288–299.
19. Ding, D., Qi, W., Jiang H, et al. 2007, Mefloquine induced apoptosis in hair cells and spiral ganglion neurons in cochlear organotypic cultures, Abstr Assoc Res Otolaryngol.
20. Yu, D., Ding, D., Salvi R. 2008, Ototoxicity of mefloquine in vestibular organotypic cultures, Abstr Assoc Res Otolaryngol.
21. Ding, D., Jiang, T., Qi, W., et al. Science of the inner ear. Chinese Science and Technology Publishing Company, 302–307, 2010.
22. Wang, Y., Sun, X., Wu, J., et al. Casein kinase 1alpha interacts with RIP1 and regulates NF–kappaB activation. Biochemistry 47:1 (2008), 441–448.
23. Silvestrini, R., Veneroni, S., Daidone, M.G., et al. The Bcl–2 protein: a prognostic indicator strongly related to p53 protein in lymph node–negative breast cancer patients. J Natl Cancer Inst 86:7 (1994), 499–504.
24. Park, S.A., Park, H.J., Lee, H.J., et al. Bcl–2 blocks cisplatin–induced apoptosis by suppression of ERK–mediated p53 accumulation in B104 cells. Brain Res Mol Brain Res 93:1 (2001), 18–26.
25. Palacios, G., Moll, U.M., Mitochondrially targeted wild–type p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 25:45 (2006), 6133–6139.
26. Haupt, S., Berger, M., Goldberg, Z., et al. Apoptosis – the p53 network. J Cell Sci 116:Pt 20 (2003), 4077–4085.
27. Haupt, S., Louria–Hayon, I., Haupt, Y., P53 licensed to kill? Operating the assassin. J Cell Biochem 88:1 (2003), 76–82.
28. Ding, D., Jiang, H., He, J., et al. Proteomic Analysis of Mefloquine Ototoxicity. Abstr Assoc Res Otolaryngol, 2009.
29. Dhillon, A.S., Hagan, S., Rath, O., et al. MAP kinase signalling pathways in cancer. Oncogene 26:22 (2007), 3279–3290.